Robin Farmanfarmaian
About Robin Farmanfarmaian
Robin Farmanfarmaian is a professional speaker, entrepreneur and angel investor based in Silicon Valley. Crunchbase lists her current role as Professional Speaker at BigSpeak Speakers Bureau. Other speaker bios describe her as CEO and co-founder of ArO, an early-stage software and device company working on dynamic vision correction and eye health monitoring.
She has been involved with more than 20 early-stage startups in healthcare, biotech, pharma, med device and digital health. One bio says she co-founded 5 of them. Those include the Organ Preservation Alliance, a non-profit that worked with DARPA, the DoD and the White House to fund scientists and build a roadmap for cryopreservation and tissue engineering for organ transplants. She also co-founded Face Touch Aware.
She has written four books: The Patient as CEO (2015), The Thought Leader Formula (2019), Facilitating Virtual Events (2020), and How AI Can Democratize Healthcare (2022), co-written with Michael Ferro. Her bureau profile cites more than 180 speaking engagements in 15 countries.
Her bios describe her as an angel investor focused on healthcare and biotech companies that could reach 100M or more patients. Crunchbase records 1 investment, 1 portfolio company and 1 exit, with no lead investments. Her own bios name more investments than that, so Crunchbase looks incomplete.
Investments named in her bios include Invicta Medical (sleep apnea), Dance Biopharm (inhaled insulin with a connected device), Rational Vaccines and Aerami. The sources do not give investment years or amounts.
Her bureau profile says she is involved with several emerging healthcare technology companies. Four of them are ChiroScript AI, a generative AI medical scribe; iSono Health, a portable AI-driven ultrasound for breast cancer detection; CompanionIQ, an AI companion for post-surgical patients, seniors and veterans; and ConceptVines, which that bio describes as AI infrastructure software. Elsewhere ConceptVines is described as a VC fund and product engineering firm. The sources do not say whether each of these is an investment or an advisory role.
She has also worked with small molecules found through AI drug discovery for cancer (p53 and AhR pathways). Her keynote topics center on clinical-grade sensors, AI reimbursement, imaging analysis and precision medicine.
Her public focus is healthcare and biotech: digital health, medical devices, pharma, longevity, remote patient monitoring and care delivery moving to the home. The companies she names are early-stage. She is based in the San Francisco Bay Area. No check size, fund size or stated investment criteria were found.
- Invicta Medical: medical technology company for sleep apnea; listed as an investment, year not public.
- Dance Biopharm: inhaled insulin with a smart, connected device; listed as a recent investment in an older bio, year not public.
- Rational Vaccines: listed as an investment, year not public.
- Aerami: listed as an investment, year not public.
- Luxsonic Technologies: portable, modular VR radiology reading room; she is an advisor.
- Alacrity Care: remote patient monitoring and data analytics for oncology; she is an advisor.
- X-Therma: cryopreservation for cell therapies, IVF and organ transplants; she is an advisor.
- ConceptVines: VC fund and product engineering firm; she is an advisor.
- crunchbase.com/person/robin-farman-farmaian
- bigspeak.com/speakers/robin-farmanfarmaian
- apbspeakers.com/speaker/robin-farmanfarmaian
- twinglobal.org/twin-global/speakers/robin-farmanfarmaian
- longevity-book.com/robin-farmanfarmaian
- democratizinghealthcare.ai/robin-farmanfarmaian
- thekeynotecurators.com/speaker/robin-farmanfarmaian
- linkedin.com/in/robinfarmanfarmaian
Investing activity
Robin Farmanfarmaian has made 1 investment according to Crunchbase across 1 portfolio company, and has seen 1 exit and founded 1 company.
Deals
Frequently asked questions about Robin Farmanfarmaian
Does Robin Farmanfarmaian invest in AI startups?
Yes, in healthcare AI. Her bureau bio lists involvement with ChiroScript AI, iSono Health and CompanionIQ, among others. The sources do not say which of these are investments and which are advisory roles.
What stage does Robin Farmanfarmaian invest in?
Her bios describe early-stage healthcare, biotech and medical device companies. No specific round or stage is stated publicly.
What is Robin Farmanfarmaian's check size?
It is not public. No check size or fund size was found in her bios or in Crunchbase.
What does Robin Farmanfarmaian look for in a company?
Her bios say she focuses on cutting-edge technology that could impact 100M people or more. She has not published detailed investment criteria.
Which companies has Robin Farmanfarmaian invested in?
Her bios name Invicta Medical, Dance Biopharm, Rational Vaccines and Aerami. She also advises Luxsonic Technologies, Alacrity Care, X-Therma and ConceptVines.
Is Robin Farmanfarmaian a founder as well as an investor?
Yes. She co-founded the Organ Preservation Alliance and Face Touch Aware, and is described as CEO and co-founder of ArO.
Is Robin Farmanfarmaian an angel investor?
Yes. Robin Farmanfarmaian invests personally as an angel and is Professional Speaker at BigSpeak Speakers Bureau. Crunchbase counts 1 investment and 1 exit.
Where is Robin Farmanfarmaian based?
Robin Farmanfarmaian is based in San Francisco, California, United States.
How can founders reach Robin Farmanfarmaian?
Founders on Lounge can see Robin Farmanfarmaian's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with them under Warm Paths, and add Robin Farmanfarmaian to their Investor Pipeline to track the conversation.